81 results
Balloon- vs self-expanding valve systems for failed small surgical aortic valve bioprostheses
26 Oct 2022
Edoardo provides us with the cardiac surgeon's point of view!
The present trial aimed to clarify the hemodynamic results between balloon-expandable valve (BEV) (SAPIEN 3 ULTRA - Edwards) and self-expandable valve (SEV) (EVOLUT R/Pro/Pro+ - Medtronic) in case of dysfunctional small-sized surgical bio-prosthesis.
Reviewer
Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score
19 Oct 2022
The new analysis from the COAPT trial indicated that lower secondary mitral regurgitation by TEER was strongly associated with reduced heart failure hospitalization, all-cause mortality, and improved quality of life as compared with a higher degree of residual MR.
Reviewer
Reviewer
Acute kidney injury following tricuspid transcatheter edge-to-edge repair
17 Oct 2022
Although tricuspid regurgitation has for a long time been “the forgotten valve”, recently there has been a rising awareness of the disease with several important studies investigating its pathophysiology and treatment.
Reviewer
Reviewer
1-year outcomes of Cardioband Tricuspid Valve Reconstruction System early feasibility study
10 Oct 2022
Reviewer
Reviewer
Leaflet-to-annulus index and residual tricuspid regurgitation following tricuspid transcatheter edge-to-edge repair
21 Jun 2022
As the relationship between leaflet length and annular dimension becomes highly relevant in TR pathophysiology, the present study aimed to evaluate the impact of tricuspid leaflet-to-annulus mismatch on outcomes after T-TEER.
Reviewer
Reviewer
Reviewer
Commissural alignment after balloon-expandable transcatheter aortic valve replacement is associated with improved hemodynamic outcomes
20 Jun 2022
This study aimed at investigating the impact of commissural misalignment on clinical outcomes and hemodynamic performance of balloon-expandable devices.
Reviewer
Reviewer
Transcatheter aortic valve replacement with self-expanding ACURATE neo2
20 Jun 2022
This study investigated the short-term safety and efficacy of the new valve ACURATE neo2 in comparison to the first neo model in a real-world population.
Reviewer
Reviewer
Prognostic impact of extra–mitral valve cardiac involvement in patients with primary mitral regurgitation
17 Jun 2022
This report builds up the evidence on the relevance of extra-valvular cardiac damage staging / involvement as a main predictor of adverse events in patients with VHD undergoing intervention, either surgical or percutaneous.
Reviewer
Reviewer
Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial
16 Jun 2022
The UK TAVI trial sought to compare TAVI with SAVR in patients with severe, symptomatic aortic stenosis and moderately increased surgical risk.
Reviewer
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE Neo2
09 Jun 2022
The ACURATE neo2 valve was developed to reduce the risk of paravalvular AR with an increased sealing skirt. This retrospective study aimed to compare TAVI with the ACURATE neo and neo2 devices.
Reviewer
Reviewer
